Edition:
United States

People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.61USD
30 Sep 2016
Change (% chg)

$0.01 (+0.63%)
Prev Close
$1.60
Open
$1.59
Day's High
$1.68
Day's Low
$1.56
Volume
8,455
Avg. Vol
47,221
52-wk High
$3.52
52-wk Low
$1.40

Emigh, James 

Mr. James F. Emigh is an Vice President of Corporate Development of Acura Pharmaceutical Technologies, Inc. since October 2011. From April 2004 to October 2011, Mr. Emigh was our Vice President of Marketing and Administration. Prior to such time, Mr. Emigh was our Vice President of Sales and Marketing. Mr. Emigh joined us in May, 1998, serving first as Executive Director of Customer Relations and then as Vice President of Operations. Mr. Emigh holds a Bachelor of Pharmacy degree from Washington State University and a Masters of Business Administration from George Mason University.

Basic Compensation

Total Annual Compensation, USD 172,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 24,948
Fiscal Year Total, USD 196,948

Options Compensation

  Quantity Market Value
Exercisable 213,250 8,404.00
Unexercisable 186,750 25,211.00
Exercised 6,225 3,237.00
Name Fiscal Year Total

Robert Jones

503,424

Peter Clemens

363,160

Robert Seiser

196,948

J. Bradley Rivet

209,422

Albert Brzeczko

351,528

James Emigh

196,948
As Of  30 Dec 2014